Detalles de la búsqueda
1.
Interstitial lung disease in patients with systemic sclerosis: what can we learn from the SENSCIS trial?
Clin Exp Rheumatol
; 41(8): 1713-1719, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37534955
2.
Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-É inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis.
Expert Rev Mol Diagn
; 22(1): 101-109, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937469
Resultados
1 -
2
de 2
1
Próxima >
>>